BOSTON, July 11, 2017, MRMD, (GLOBE NEWSWIRE) — MariMed Inc. (OTCQB:MRMD) in June completed a capital raise of $5,150,000 to fund development and expansion of client medical cannabis facilities in Maryland and Delaware and marketing of MariMed’s Kalm Fusion® line of precision dosed cannabis products into additional states. MariMed, an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities, assisted two clients in opening medical cannabis facilities in the past two months and hasRead more
- Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing Facility in India
- Cannabis Strategic Files Provision Patent for Unique Cannabis Smoke Filtration Device
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
- Pura Naturals Launches New Line of Health and Beauty Products with CBD and Hemp Seed Oils
- Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More